Annexin Pharmaceuticals AB Net Asset Quality Index
Annexin Pharmaceuticals AB net asset quality index. Annexin Pharmaceuticals AB (ANNX) has a Net Asset Quality Index of 72.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr19.98 Million minus total liabilities of Skr5.56 Million yields net assets of Skr14.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Annexin Pharmaceuticals AB (ANNX) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Annexin Pharmaceuticals AB (2014–2025)
Net asset quality index of Annexin Pharmaceuticals AB from 2014 to 2025. This chart shows how Annexin Pharmaceuticals AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 72.2%, representing net assets of Skr14.42 Million against total assets of Skr19.98 Million SEK. Check ANNX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annexin Pharmaceuticals AB Net Asset Quality Index by Year (2014–2025)
Annexin Pharmaceuticals AB net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Annexin Pharmaceuticals AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ANNX stock market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.7% | Skr24.93 Million | Skr30.16 Million | Skr5.22 Million | ▲ +10.6 pp |
| 2024 | 72.0% | Skr13.71 Million | Skr19.04 Million | Skr5.32 Million | ▲ +1.7 pp |
| 2023 | 70.3% | Skr18.81 Million | Skr26.76 Million | Skr7.95 Million | ▼ -11.9 pp |
| 2022 | 82.2% | Skr30.15 Million | Skr36.68 Million | Skr6.53 Million | ▼ -6.3 pp |
| 2021 | 88.5% | Skr46.73 Million | Skr52.79 Million | Skr6.06 Million | ▲ +6.5 pp |
| 2020 | 82.0% | Skr20.64 Million | Skr25.16 Million | Skr4.52 Million | ▲ +10.4 pp |
| 2019 | 71.6% | Skr11.49 Million | Skr16.04 Million | Skr4.55 Million | ▼ -14.9 pp |
| 2018 | 86.6% | Skr39.85 Million | Skr46.04 Million | Skr6.19 Million | ▲ +7.3 pp |
| 2017 | 79.2% | Skr24.44 Million | Skr30.85 Million | Skr6.41 Million | ▲ +12.8 pp |
| 2016 | 66.4% | Skr15.57 Million | Skr23.46 Million | Skr7.88 Million | ▲ +70.7 pp |
| 2015 | -4.4% | Skr-137.00K | Skr3.15 Million | Skr3.28 Million | ▼ -77.8 pp |
| 2014 | 73.4% | Skr2.71 Million | Skr3.69 Million | Skr981.14K | — |